J.W. Cole Advisors, Inc. Tg Therapeutics, Inc. Transaction History
J.W. Cole Advisors, Inc.
- $2.33 Billion
- Q3 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 15,803 shares of TGTX stock, worth $508,224. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,803
Previous 15,700
0.66%
Holding current value
$508,224
Previous $279,000
32.26%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$495 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$366 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$292 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$115 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$103 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.67B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...